Neue Aspekte in der Behandlung von Schilddrüsenkarzinomen: Highlights vom ASCO-Kongress 2019
Standard
Neue Aspekte in der Behandlung von Schilddrüsenkarzinomen: Highlights vom ASCO-Kongress 2019. / Möckelmann, N; Betz, C.
in: HNO, Jahrgang 67, Nr. 12, 12.2019, S. 925-930.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Neue Aspekte in der Behandlung von Schilddrüsenkarzinomen: Highlights vom ASCO-Kongress 2019
AU - Möckelmann, N
AU - Betz, C
PY - 2019/12
Y1 - 2019/12
N2 - The majority of patients with thyroid cancer have a remarkably good chance of cure in the context of surgical treatment, due to their mostly local tumor spread. However, a small proportion of patients with advanced and metastatic thyroid tumors usually require multimodality treatment. Abstracts from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting are summarized in this review, to provide insights into current aspects of thyroid carcinoma treatment. In addition to innovations in the treatment of radioiodine-refractory differentiated and medullary thyroid carcinoma, current approaches to anaplastic thyroid carcinoma are presented and critically interpreted.
AB - The majority of patients with thyroid cancer have a remarkably good chance of cure in the context of surgical treatment, due to their mostly local tumor spread. However, a small proportion of patients with advanced and metastatic thyroid tumors usually require multimodality treatment. Abstracts from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting are summarized in this review, to provide insights into current aspects of thyroid carcinoma treatment. In addition to innovations in the treatment of radioiodine-refractory differentiated and medullary thyroid carcinoma, current approaches to anaplastic thyroid carcinoma are presented and critically interpreted.
KW - Combined Modality Therapy
KW - Congresses as Topic
KW - Humans
KW - Immunotherapy
KW - Iodine Radioisotopes
KW - Thyroid Neoplasms/therapy
U2 - 10.1007/s00106-019-00764-5
DO - 10.1007/s00106-019-00764-5
M3 - SCORING: Review
C2 - 31628529
VL - 67
SP - 925
EP - 930
JO - HNO
JF - HNO
SN - 0017-6192
IS - 12
ER -